Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Korean Authorities Mull New Steps, Probe Over Olmutinib Events

Oct 03 2016

• By Jung Won Shin

Drugs question mark

Related Content

Boehringer Ingelheim Bullish In Oncology Despite Olmutinib U-Turn

Oct 02 2016

Surprise Boehringer Decision Turns Hanmi Investors’ Hopes To Despair

Sep 30 2016

Hanmi Does It Again - RAF Inhibitor Goes To Genentech In $910m Deal

Sep 30 2016

Related Companies

Hanmi Pharmaceutical Co., Ltd.

Boehringer Ingelheim GmbH

Zai Lab Ltd.

Genentech, Inc.

Roche Holding AG

Additional Topics

South Korea Asia Pacific Safety Companies BioPharmaceutical Cancer

More from South Korea

More from Focus On Asia

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window